Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Study’s Novelty/Excerpt This review systematically explores the anti-ulcerogenic potential of medicinal plants, emphasizing their bioactive compounds and pharmacological properties, a topic underexplored in the context of peptic ulcer management. The inclusion of 33 studies from 2010-2024 offers a comprehensive analysis of plant species like Curcuma longa, Moringa oleifera, and Allium sativum, highlighting their multiple mechanisms of action, including anti-inflammatory and anti-H. pylori effects. The findings highlights the potential of these ethnobotanical resources to complement or replace synthetic drugs, addressing the growing need for safer and more effective peptic ulcer treatments. Full Abstract The common gastrointestinal ailment known as peptic ulcer is characterized by damage to the stomach and duodenum's mucosal integrity, mostly as a result of an unbalanced interaction between mucus production and other defensive systems and aggressive elements like gastric acid. Pain, loss of appetite, bloating, nausea, perforations, weight loss, bloody stools, or vomiting are some of the signs that identify the condition. The necessity for efficient treatment plans is highlighted by the rising incidence of peptic ulcers, which is made worse by conditions including Helicobacter pylori infection and NSAID use. Herbal drugs are emerging as alternative remedies for various health conditions. With an emphasis on the bioactive chemicals and pharmacological properties of these plants, this review investigates the therapeutic potential of medicinal plants in the management of peptic ulcers. A PRISMA-compliant systematic review was carried out to evaluate the anti-ulcerogenic qualities of a variety of medicinal plants. We looked through scientific databases, including PubMed, Scopus, and Google Scholar, to find pertinent research that was published between 2010 and 2024. Terms like "peptic ulcer," "anti-ulcer plants," "plant-derived drugs for peptic ulcer," "herbal drugs," and "phytomedicine for peptic ulcer" were used in the search. Thirty-three (33) full-text articles out of 2,650 entries that were examined and found to match the inclusion criteria were included. Plant species, bioactive chemicals, and their proven effects on peptic ulcers in preclinical research were the main topics of data extraction. This review highlights the many modes of action and therapeutic applications of the several medicinal plant extracts that have been connected to anti-ulcer properties. The ethnobotanical plants were discovered to be a rich source of phytochemicals, including flavonoids, alkaloids, tannins, simple phenols, and saponins. Numerous therapeutic plants with potent anti-ulcerogenic, anti-inflammatory, and antibacterial qualities have been found to exist, such as Curcuma longa, Moringa oleifera, and Allium sativum. These plants improve mucosal defence systems, lower stomach acid output, control inflammatory mediators, and inhibit H. pylori, offering considerable therapeutic potential. More research is required to fully understand the medical potential of these natural medicines, as the findings show that they can successfully complement current treatments for peptic ulcers, lowering dependency on synthetic pharmaceuticals and minimizing associated adverse effects.
Study’s Novelty/Excerpt This review systematically explores the anti-ulcerogenic potential of medicinal plants, emphasizing their bioactive compounds and pharmacological properties, a topic underexplored in the context of peptic ulcer management. The inclusion of 33 studies from 2010-2024 offers a comprehensive analysis of plant species like Curcuma longa, Moringa oleifera, and Allium sativum, highlighting their multiple mechanisms of action, including anti-inflammatory and anti-H. pylori effects. The findings highlights the potential of these ethnobotanical resources to complement or replace synthetic drugs, addressing the growing need for safer and more effective peptic ulcer treatments. Full Abstract The common gastrointestinal ailment known as peptic ulcer is characterized by damage to the stomach and duodenum's mucosal integrity, mostly as a result of an unbalanced interaction between mucus production and other defensive systems and aggressive elements like gastric acid. Pain, loss of appetite, bloating, nausea, perforations, weight loss, bloody stools, or vomiting are some of the signs that identify the condition. The necessity for efficient treatment plans is highlighted by the rising incidence of peptic ulcers, which is made worse by conditions including Helicobacter pylori infection and NSAID use. Herbal drugs are emerging as alternative remedies for various health conditions. With an emphasis on the bioactive chemicals and pharmacological properties of these plants, this review investigates the therapeutic potential of medicinal plants in the management of peptic ulcers. A PRISMA-compliant systematic review was carried out to evaluate the anti-ulcerogenic qualities of a variety of medicinal plants. We looked through scientific databases, including PubMed, Scopus, and Google Scholar, to find pertinent research that was published between 2010 and 2024. Terms like "peptic ulcer," "anti-ulcer plants," "plant-derived drugs for peptic ulcer," "herbal drugs," and "phytomedicine for peptic ulcer" were used in the search. Thirty-three (33) full-text articles out of 2,650 entries that were examined and found to match the inclusion criteria were included. Plant species, bioactive chemicals, and their proven effects on peptic ulcers in preclinical research were the main topics of data extraction. This review highlights the many modes of action and therapeutic applications of the several medicinal plant extracts that have been connected to anti-ulcer properties. The ethnobotanical plants were discovered to be a rich source of phytochemicals, including flavonoids, alkaloids, tannins, simple phenols, and saponins. Numerous therapeutic plants with potent anti-ulcerogenic, anti-inflammatory, and antibacterial qualities have been found to exist, such as Curcuma longa, Moringa oleifera, and Allium sativum. These plants improve mucosal defence systems, lower stomach acid output, control inflammatory mediators, and inhibit H. pylori, offering considerable therapeutic potential. More research is required to fully understand the medical potential of these natural medicines, as the findings show that they can successfully complement current treatments for peptic ulcers, lowering dependency on synthetic pharmaceuticals and minimizing associated adverse effects.
The main objective of this research was to create and evaluate the efficacy of orally disintegrating tablets containing sumatriptan succinate at a dosage of 25 milligrammes, a medicine commonly prescribed for the treatment of migraines. The tablets are made using the direct compression method. In order to achieve best results, the formulations were enriched with microcrystalline cellulose of varying composition (Avicel PH 102), mannitol as a diluent, crospovidone, croscaramellose, and sodium starch glycollate as superdisintegrants. Carbomer (carbopol 940), Sodium CMC, and Sodium Alginate were among the other excipients that were used. When used at varying doses, these excipients act as disintegrants. In addition, magnesium stearate was used as a substance to reduce friction, while talc was used as a substance to improve flow. We assessed each of the excipients to ascertain their compatibility with the model drug. The findings revealed no occurrence of any physical or chemical interaction. Before compression, the preformulation features of the tablet blend were examined. The criteria considered were bulk density, tapped density, compressibility index, and hausner ratio. An assessment was carried out on central tablets to ascertain their dimensions, firmness, tendency to crumble, variability in weight, rate of disintegration, and uniformity of drug content properties. Furthermore, an investigation was conducted to examine the impact of these variables on the release of the drug. The drug release studies were performed in vitro using the USP dissolving apparatus-II (paddle type) with a phosphate buffer solution at a pH of 6.8. The experiments were conducted at a speed of 50 revolutions per minute at a temperature of 37 degrees Celsius, with a standard deviation of 5 degrees Celsius. The sampling was conducted at consistent intervals of 2, 4, 6, 8, and 10 minutes. After each withdrawal, an equivalent volume of dissolving medium was replaced with the sample. The ultraviolet (UV) method is employed to evaluate the cumulative quantity of medications that have been discharged at different time intervals. Based on the evaluation results, the F-3 trial formulation, which included 6% crospovidone, was selected as the superior formulation among the superdisintegrants. Conversely, the F-10 trial formulation, which included 2% carbopol 940p, was selected as the superior formulation compared to other basic disintegrants.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.